Pruritis
Showing 1 - 25 of 1,078
Uremic Pruritis Trial in Alexandria (sertraline, )
Completed
- Uremic Pruritis
- sertraline
- placebo
-
Alexandria, EgyptFaculty of Medicine, Aexandria University
Dec 12, 2022
Refractory Uremic Pruritis Trial in Alexandria (NB UVB phototherapy, Pregabalin)
Recruiting
- Refractory Uremic Pruritis
- NB UVB phototherapy
- Pregabalin
-
Alexandria, EgyptFaculty of Medicine
Jul 23, 2021
Allergic Rhinitis, Asthma Trial in Brooklyn (Minocycline Topical, Placebos)
Recruiting
- Allergic Rhinitis
- Asthma
- Minocycline Topical
- Placebos
-
Brooklyn, New YorkSUNY Downstate Medical Center
Oct 13, 2021
Magnesium Infusion in Post-spinal Opioid Pruritis Trial in Mansoura (IV infusion, intrathecal fentanyl)
Recruiting
- Magnesium Infusion in Post-spinal Opioid Pruritis
- IV infusion
- intrathecal fentanyl
-
Mansoura, Dakahlia, EgyptAnesthesia department,Faculty of medicine, Mansoura univerisety
Sep 2, 2020
Prurigo Nodularis, Pruritis Trial in Worldwide (vixarelimab, Placebo)
Active, not recruiting
- Prurigo Nodularis
- Pruritis
- vixarelimab
- Placebo
-
Anniston, Alabama
- +76 more
Jan 3, 2023
Allergic Conjunctivitis Trial in Andover (olopatadine HCl ophthalmic solution 0.7%), Fluticasone Propionate, Tears Naturale)
Recruiting
- Allergic Conjunctivitis
- olopatadine hydrochloride ophthalmic solution 0.7%)
- +3 more
-
Andover, MassachusettsAndover Eye Associates
Jul 18, 2022
Spinal Anesthesia, Dexamethasone Trial in Halifax (Dexamethasone, Metoclopramide)
Not yet recruiting
- Spinal Anesthesia
- Dexamethasone
-
Halifax, Nova Scotia, CanadaIWK Health Centre
Feb 8, 2023
End Stage Renal Disease, Pruritus Trial in Winnipeg (Nabilone 0.5 MG Oral Capsule, Placebo Nabilone)
Not yet recruiting
- End Stage Renal Disease
- Pruritus
- Nabilone 0.5 MG Oral Capsule
- Placebo Nabilone
-
Winnipeg, Manitoba, CanadaSeven Oaks General Hospital
May 16, 2022
Assess Disease Activity in Adolescent and Adult Atopic
Recruiting
- Atopic Dermatitis
-
Heidelberg, Baden-Wuerttemberg, Germany
- +99 more
Nov 24, 2022
Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma Trial in Chengdu (Tacrolimus ointment)
Recruiting
- Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma
- Tacrolimus ointment
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Jan 15, 2023
Dermatophyte Infection, Terbinafine Adverse Reaction, Itraconazole Adverse Reaction Trial in Rawalpindi (Terbinafine Pill,
Completed
- Dermatophyte Infection
- +2 more
- Terbinafine Pill
- Itraconazole capsule
-
Rawalpindi, Punjab, PakistanPak Emirates Military Hospital
Mar 19, 2022
Atopic Dermatitis, Psoriasis, Asthma Trial in United Kingdom (EDP1867, Placebo)
Completed
- Atopic Dermatitis
- +2 more
- EDP1867
- Placebo
-
Manchester, Greater Manchester, United Kingdom
- +6 more
Oct 6, 2022
Minimal Invasive Heart Surgery, Rhomboid Intercostal Nerve Block Trial in Istanbul (Rhomboid Intercostal Nerve Block)
Recruiting
- Minimal Invasive Heart Surgery
- Rhomboid Intercostal Nerve Block
- Rhomboid Intercostal Nerve Block
-
İstanbul, TurkeyKoc University
May 20, 2023
Rhinitis, Allergic, Seasonal, Rhinitis, Allergic, Perennial Trial (5-mg Desloratadine, Placebo)
Completed
- Rhinitis, Allergic, Seasonal
- Rhinitis, Allergic, Perennial
- 5-mg Desloratadine
- Placebo
- (no location specified)
Feb 7, 2022
Urticaria Trial in Syracuse (Doxepin, Diphenhydramine)
Recruiting
- Urticaria
-
Syracuse, New YorkSUNY Upstate Medical University
May 17, 2022
Atopic Dermatitis Trial (Tofacitinib Citrate, ointment)
Not yet recruiting
- Atopic Dermatitis
- Tofacitinib Citrate
- placebo ointment
- (no location specified)
Aug 2, 2022
Palmoplantar Pustulosis Trial in Japan (Apremilast, Placebo)
Recruiting
- Palmoplantar Pustulosis
- Apremilast
- Placebo
-
Nagakute-shi, Aichi, Japan
- +37 more
Jul 22, 2022
Allergic Contact Dermatitis Trial in Canada, United States (EB01 Cream Placebo, EB01 Cream 0.2%, EB01 Cream 1.0%)
Recruiting
- Allergic Contact Dermatitis
- EB01 Cream Placebo
- +3 more
-
Long Beach, California
- +12 more
Mar 21, 2022